These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 18027309)

  • 41. Clean Olympians? Doping and anti-doping: the views of talented young British athletes.
    Bloodworth A; McNamee M
    Int J Drug Policy; 2010 Jul; 21(4):276-82. PubMed ID: 20056401
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Kinesio taping and jump performance in elite female track and field athletes and jump performance in elite female track and field athletes.
    Schiffer T; Möllinger A; Sperlich B; Memmert D
    J Sport Rehabil; 2015 Feb; 24(1):47-50. PubMed ID: 24959912
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gene doping.
    Harridge SD; Velloso CP
    Essays Biochem; 2008; 44():125-38. PubMed ID: 18384287
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The use of dietary supplements by athletes.
    Maughan RJ; Depiesse F; Geyer H;
    J Sports Sci; 2007; 25 Suppl 1():S103-13. PubMed ID: 18049988
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Doping droops.
    Chaturvedi A; Chaturvedi H; Kalra J; Kalra S
    Indian J Physiol Pharmacol; 2007; 51(2):118-30. PubMed ID: 18175655
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence of asthma-like symptoms, asthma and its treatment in elite athletes.
    Lund T; Pedersen L; Larsson B; Backer V
    Scand J Med Sci Sports; 2009 Apr; 19(2):174-8. PubMed ID: 18282226
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nutritional Supplement Use by Dutch Elite and Sub-Elite Athletes: Does Receiving Dietary Counseling Make a Difference?
    Wardenaar FC; Ceelen IJ; Van Dijk JW; Hangelbroek RW; Van Roy L; Van der Pouw B; De Vries JH; Mensink M; Witkamp RF
    Int J Sport Nutr Exerc Metab; 2017 Feb; 27(1):32-42. PubMed ID: 27615123
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Elite athletes' perceptions of the effects of illicit drug use on athletic performance.
    Thomas JO; Dunn M; Swift W; Burns L
    Clin J Sport Med; 2010 May; 20(3):189-92. PubMed ID: 20445359
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Success in elite cycling: A prospective and retrospective analysis of race results.
    Schumacher YO; Mroz R; Mueller P; Schmid A; Ruecker G
    J Sports Sci; 2006 Nov; 24(11):1149-56. PubMed ID: 17175613
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Doping, drugs and drug abuse among adolescents in the State of Thuringia (Germany): prevalence, knowledge and attitudes.
    Wanjek B; Rosendahl J; Strauss B; Gabriel HH
    Int J Sports Med; 2007 Apr; 28(4):346-53. PubMed ID: 17024651
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evidence on ergogenic action of glucocorticoids as a doping agent risk.
    Duclos M
    Phys Sportsmed; 2010 Oct; 38(3):121-7. PubMed ID: 20959705
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nutritional ergogenic aids and exercise performance.
    Maughan RJ
    Nutr Res Rev; 1999 Dec; 12(2):255-80. PubMed ID: 19087454
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Doing supplements to improve performance in club cycling: a life-course analysis.
    Stewart B; Outram S; Smith AC
    Scand J Med Sci Sports; 2013 Dec; 23(6):e361-72. PubMed ID: 23909650
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of caffeine supplementation on physical performance and mood dimensions in elite and trained-recreational athletes.
    Jodra P; Lago-Rodríguez A; Sánchez-Oliver AJ; López-Samanes A; Pérez-López A; Veiga-Herreros P; San Juan AF; Domínguez R
    J Int Soc Sports Nutr; 2020 Jan; 17(1):2. PubMed ID: 31900166
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Developing strategies for detection of gene doping.
    Baoutina A; Alexander IE; Rasko JE; Emslie KR
    J Gene Med; 2008 Jan; 10(1):3-20. PubMed ID: 18081214
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Administration of Caffeine in Alternate Forms.
    Wickham KA; Spriet LL
    Sports Med; 2018 Mar; 48(Suppl 1):79-91. PubMed ID: 29368182
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phosphodiesterase Type 5 Inhibitors, Sport and Doping.
    Di Luigi L; Sansone M; Sansone A; Ceci R; Duranti G; Borrione P; Crescioli C; Sgrò P; Sabatini S
    Curr Sports Med Rep; 2017; 16(6):443-447. PubMed ID: 29135645
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Caffeine: implications for alertness in athletes.
    Rogers NL; Dinges DF
    Clin Sports Med; 2005 Apr; 24(2):e1-13, x-xi. PubMed ID: 15892913
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Caffeine and sports performance.
    Burke LM
    Appl Physiol Nutr Metab; 2008 Dec; 33(6):1319-34. PubMed ID: 19088794
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An improvement index to quantify the evolution of performance in running.
    Haake SJ; Foster LI; James DM
    J Sports Sci; 2014; 32(7):610-22. PubMed ID: 24073888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.